EI
NVO

EFG International’s Novo Nordisk NVO Stock Holding History

EFG International’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.61M Buy
75,252
+10,368
+16% +$445K 0.07% 258
2026
Q1 		$2.38M Sell
64,884
-85,579
-57% -$4.05M 0.05% 301
2025
Q4 		$7.66M Buy
+150,463
New +$7.69M 0.15% 115

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

EFG International's NVO Position: Q2 2026 in Review

EFG International increased its Novo Nordisk (NVO) stake by 16% in Q2 2026, buying an estimated $445K and bringing the position to 75,252 shares worth $3.61M. The position accounts for 0.07% of the portfolio, ranked #258.

EFG International first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.66M in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • EFG International held 75,252 shares of Novo Nordisk worth $3.61M as of Q2 2026.
  • EFG International bought 10,368 Novo Nordisk shares in Q2 2026, an estimated $445K.
  • Novo Nordisk made up 0.07% of EFG International's portfolio in Q2 2026, its #258 holding.
  • EFG International first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • EFG International's Novo Nordisk position peaked at $7.66M in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.